Yvette L. Kasamon

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

Leo Luznik, Javier Bolaños‐Meade, Marianna Zahurak et al. · Blood · 2010 · 404 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances

Aaron Orkin, Peter Gill, Davina Ghersi et al. · JAMA · 2021 · 313 citations · Full text

Public Health, Internal Medicine, Clinical Research Regulation +16

Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel et al. · Blood · 2015 · 300 citations · Full text

Medicine, Hematology, Immunology +14

Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome

Yvette L. Kasamon, Leo Luznik, Mary S. Leffell et al. · Biology of Blood and Marrow Transplantation · 2009 · 281 citations · Full text

Medicine, Hematology, Immunology +17

Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

Yvette L. Kasamon, Javier Bolaños‐Meade, Gabrielle T. Prince et al. · Journal of Clinical Oncology · 2015 · 239 citations

Medicine, Hematology, Immunology +17